Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
Over the last 12 months, insiders at Quanterix Corporation have bought $501,978 and sold $112,405 worth of Quanterix Corporation stock.
On average, over the past 5 years, insiders at Quanterix Corporation have bought $1.72M and sold $6.65M worth of stock each year.
Highest buying activity among insiders over the last 12 months: DONNELLY WILLIAM P (director) — $1.51M.
The last purchase of 20,200 shares for transaction amount of $501,978 was made by DONNELLY WILLIAM P (director) on 2023‑09‑08.
2024-05-14 | Sale | OLSON LAURIE J | director | 1,500 0.004% | $16.98 | $25,470 | -3.36% | |
2024-04-01 | Sale | OLSON LAURIE J | director | 1,000 0.0026% | $23.50 | $23,500 | -30.57% | |
2024-02-14 | Sale | OLSON LAURIE J | director | 1,500 0.004% | $24.35 | $36,525 | -29.64% | |
2024-01-02 | Sale | OLSON LAURIE J | director | 1,000 0.0026% | $26.91 | $26,910 | -18.50% | |
2023-09-08 | DONNELLY WILLIAM P | director | 20,200 0.0545% | $24.85 | $501,978 | -6.20% | ||
2022-08-12 | Toloue Masoud | President & CEO | 105,000 0.2829% | $10.43 | $1.1M | +22.94% | ||
2022-08-12 | DOYLE MICHAEL A | CFO and Treasurer | 15,000 0.0394% | $10.16 | $152,418 | +22.94% | ||
2022-08-11 | Hlavinka Sarah E. | 4,760 0.0132% | $10.46 | $49,788 | +26.48% | |||
2022-08-10 | WALT DAVID R | 150,000 0.4084% | $8.62 | $1.29M | +50.00% | |||
2022-08-10 | Madaus Martin D | 89,667 0.2385% | $8.43 | $755,543 | +50.00% | |||
2022-08-10 | MEISTER PAUL M | 47,957 0.1303% | $8.61 | $412,780 | +50.00% | |||
2022-08-01 | Sale | Toloue Masoud | President & CEO | 446 0.0012% | $15.61 | $6,964 | -15.97% | |
2022-08-01 | Sale | Fry John J | General Counsel & Secretary | 401 0.0011% | $15.61 | $6,261 | -15.97% | |
2022-07-13 | Sale | DOYLE MICHAEL A | CFO and Treasurer | 434 0.0012% | $18.16 | $7,879 | -30.22% | |
2022-07-05 | Sale | HRUSOVSKY E KEVIN | Executive Chairman | 960 0.0024% | $16.57 | $15,906 | -29.13% | |
2022-07-05 | Sale | Toloue Masoud | President & CEO | 432 0.0011% | $16.57 | $7,158 | -29.13% | |
2022-07-05 | Sale | Fry John J | General Counsel & Secretary | 387 0.001% | $16.57 | $6,412 | -29.13% | |
2022-06-13 | Sale | Toloue Masoud | President & CEO | 5,564 0.0153% | $15.27 | $84,955 | -15.21% | |
2022-06-02 | Sale | HRUSOVSKY E KEVIN | Executive Chairman | 712 0.0019% | $17.47 | $12,441 | -27.36% | |
2022-06-02 | Sale | Fry John J | General Counsel & Secretary | 378 0.001% | $17.47 | $6,605 | -27.36% |
DONNELLY WILLIAM P | director | 28438 0.0752% | $12.26 | 1 | 0 | |
OLSON LAURIE J | director | 13738 0.0442% | $12.26 | 0 | 4 | |
CRANDELL KEITH | 1537684 4.0648% | $12.26 | 1 | 1 | <0.0001% | |
ARCH VENTURE FUND VI LP | 10 percent owner | 1537684 4.0648% | $12.26 | 1 | 0 | <0.0001% |
WALT DAVID R | 1431312 3.7836% | $12.26 | 3 | 0 | +49.01% | |
HRUSOVSKY E KEVIN | Executive Chairman | 910249 2.4062% | $12.26 | 1 | 103 | <0.0001% |
Madaus Martin D | 254633 0.6731% | $12.26 | 1 | 52 | +50% | |
MEISTER PAUL M | 252611 0.6678% | $12.26 | 1 | 0 | +50% | |
Toloue Masoud | President & CEO | 185823 0.4912% | $12.26 | 1 | 3 | +22.94% |
Duffy David C. | SVP R&D and CTO | 54730 0.1447% | $12.26 | 0 | 36 | |
DOYLE MICHAEL A | CFO and Treasurer | 48614 0.1285% | $12.26 | 1 | 1 | +22.94% |
Fry John J | General Counsel & Secretary | 37671 0.0996% | $12.26 | 0 | 29 | |
Mattoon Dawn | Sr. VP, Diagnostics | 36876 0.0975% | $12.26 | 0 | 48 | |
Chaubal Amol | Chief Financial Officer | 30222 0.0799% | $12.26 | 0 | 15 | |
Orticerio Ernest | SVP Finance and Corporate Dev | 28802 0.0761% | $12.26 | 0 | 5 | |
Hlavinka Sarah E. | 26270 0.0694% | $12.26 | 1 | 0 | +26.48% | |
Roskey Mark T. | SVP, Strategic Partnerships | 22325 0.059% | $12.26 | 0 | 45 | |
Connolly John M | director | 4970 0.0131% | $12.26 | 1 | 0 | +26.86% |
DRISCOLL JOSEPH | Chief Financial Officer | 4388 0.0116% | $12.26 | 0 | 6 | |
DEKKERS MARIJN E | director | 2270 0.006% | $12.26 | 1 | 5 | <0.0001% |
BlackRock | $73.57M | 8.16 | 3.12M | -2.14% | -$1.61M | <0.01 | |
AllianceBernstein | $59.64M | 6.62 | 2.53M | +351.8% | +$46.44M | 0.02 | |
Millennium Management LLC | $53.37M | 5.92 | 2.27M | +2.52% | +$1.31M | 0.04 | |
The Vanguard Group | $48.76M | 5.41 | 2.07M | +0.7% | +$339,028.41 | <0.01 | |
Lord Abbett | $41.4M | 4.59 | 1.76M | +22.85% | +$7.7M | 0.14 | |
Gilder Gagnon Howe & Co. LLC | $27.66M | 3.07 | 1.17M | -2.37% | -$671,224.52 | 0.35 | |
Portolan Capital Management | $27.4M | 3.04 | 1.16M | -10.35% | -$3.16M | 2.1 | |
Dimensional Fund Advisors | $23.48M | 2.6 | 996,636 | +2.31% | +$530,689.00 | 0.01 | |
Ashford Capital Management Inc | $19.59M | 2.17 | 831,535 | -0.04% | -$8,246.00 | 2.66 | |
Ameriprise Financial | $19.43M | 2.16 | 824,712 | +22.96% | +$3.63M | 0.01 | |
State Street | $19.21M | 2.13 | 815,487 | +0.8% | +$151,749.96 | <0.01 | |
Invesco | $19.1M | 2.12 | 810,532 | -6.84% | -$1.4M | <0.01 | |
Geode Capital Management | $18.83M | 2.09 | 798,968 | +4.6% | +$827,582.63 | <0.01 | |
Emerald Advisers, Inc. | $16.62M | 1.84 | 705,447 | +22.8% | +$3.09M | 0.68 | |
Granahan Investment Management | $15.83M | 1.76 | 671,779 | +0.74% | +$115,915.20 | 0.56 | |
Baillie Gifford Co | $14.69M | 1.63 | 623,355 | -1.3% | -$193,616.08 | 0.01 | |
Tikvah Management Llc | $13.47M | 1.49 | 571,619 | 0% | +$0 | 4.24 | |
Nuveen | $13.39M | 1.49 | 568,309 | +8.47% | +$1.05M | <0.01 | |
EMERALD MUTUAL FUND ADVISERS TRUST | $13.17M | 1.46 | 558,841 | +17.96% | +$2M | 0.69 | |
Farallon Capital | $11.1M | 1.23 | 471,000 | +155.98% | +$6.76M | 0.08 | |
Renaissance Technologies | $10.02M | 1.11 | 425,386 | -10.39% | -$1.16M | 0.02 | |
Pura Vida Investments LLC | $8.86M | 0.98 | 375,985 | -42.27% | -$6.49M | 6.31 | |
Northern Trust | $8.44M | 0.94 | 358,405 | -2.1% | -$180,658.08 | <0.01 | |
Ubs Asset Management Americas Inc | $8.03M | 0.89 | 340,726 | +33.55% | +$2.02M | <0.01 | |
Boone Capital Management Llc | $7.78M | 0.86 | 330,151 | -41.93% | -$5.62M | 1.57 | |
Charles Schwab | $7.43M | 0.82 | 315,383 | +6.62% | +$461,116.29 | <0.01 | |
Blue Water Life Science Advisors Llc | $7.28M | 0.81 | 309,093 | +7.25% | +$492,333.32 | 6.85 | |
D. E. Shaw & Co. | $7.06M | 0.78 | 299,746 | -51.59% | -$7.53M | 0.01 | |
Prudential Financial | $6.75M | 0.75 | 286,513 | -26.57% | -$2.44M | 0.01 | |
Pier Capital LLC | $6.56M | 0.73 | 278,491 | +32.21% | +$1.6M | 0.91 | |
Goldman Sachs | $5.58M | 0.62 | 236,731 | -18.67% | -$1.28M | <0.01 | |
PLATINUM INVESTMENT MANAGEMENT LTD | $5.12M | 0.57 | 217,442 | -57.43% | -$6.91M | 0.07 | |
ROYCE & ASSOCIATES INC | $5.09M | 0.56 | 215,948 | 0% | +$0 | 0.05 | |
Morgan Stanley | $5.08M | 0.56 | 215,832 | -38.31% | -$3.16M | <0.0001 | |
Boothbay Fund Management LLC | $4.28M | 0.48 | 181,651 | -19.27% | -$1.02M | 0.14 | |
Parkman Healthcare Partners Llc | $4.15M | 0.46 | 176,112 | +20.32% | +$700,815.81 | 0.51 | |
Two Sigma Advisers LP | $4.07M | 0.45 | 172,548 | -26.96% | -$1.5M | 0.01 | |
Fuller & Thaler Asset Management, Inc. | $3.73M | 0.41 | 158,305 | -3.02% | -$116,033.01 | 0.02 | |
Bridger Management Llc | $3.65M | 0.41 | 154,900 | 0% | +$0 | 1.65 | |
AQR Capital | $3.48M | 0.39 | 147,501 | +4.9% | +$162,422.66 | 0.01 | |
CWM LLC | $3.2M | 0.36 | 135,789 | -22.77% | -$943,216.04 | 0.02 | |
Marathon Micro Partners LLC | $2.81M | 0.31 | 119,135 | +12.66% | +$315,468.45 | 0.68 | |
BNY Mellon | $2.73M | 0.3 | 115,705 | -7.7% | -$227,306.90 | <0.01 | |
Bank of America | $2.49M | 0.28 | 105,793 | +92.94% | +$1.2M | <0.0001 | |
ClariVest Asset Management LLC | $2.46M | 0.27 | 104,570 | -0.23% | -$5,560.16 | 0.26 | |
Oberweis Asset Management Inc | $2.35M | 0.26 | 99,700 | +13.55% | +$280,364.00 | 0.17 | |
JPMorgan Chase | $2.2M | 0.24 | 93,263 | +3.54% | +$75,156.43 | <0.0001 | |
Frontier Capital Management Co | $2.2M | 0.24 | 93,211 | -47.33% | -$1.97M | 0.02 | |
Picton Mahoney Asset Management | $2.03M | 0.23 | 86,092 | +1,598.07% | +$1.91M | 0.1 | |
China Universal Asset Management Co., Ltd. | $2M | 0.22 | 85,019 | 0% | +$0 | 0.18 |